Invacare

NorthStar Medical Technologies, LLC Announces Appointment of Barbara Bodem and David Keeling to Board of Managers

Retrieved on: 
Tuesday, February 27, 2024

NorthStar Medical Technologies, LLC, parent company of NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, today announced the appointment of Barbara W. Bodem and David Keeling to its Board of Managers, effective February 12, 2024.

Key Points: 
  • NorthStar Medical Technologies, LLC, parent company of NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, today announced the appointment of Barbara W. Bodem and David Keeling to its Board of Managers, effective February 12, 2024.
  • "We are pleased to welcome Barbara and David to the NorthStar Board," said Stephen Merrick, Executive Chairman of NorthStar.
  • She is currently a Board Director for Enovis Corporation (NYSE: ENOV), Option Care Health (NASDAQ: OPCH) and BioMarin Pharmaceutical (NASDAQ: BMRN).
  • “2024 and the next few years will be critical for NorthStar,” said Frank Scholz, Ph.D., NorthStar President and Chief Executive Officer.

BioMarin Announces Governance Enhancements and Value Creation Initiatives

Retrieved on: 
Wednesday, December 20, 2023

SAN RAFAEL, Calif., Dec. 20, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today announced several initiatives to enhance corporate governance and long-term shareholder value creation.

Key Points: 
  • SAN RAFAEL, Calif., Dec. 20, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today announced several initiatives to enhance corporate governance and long-term shareholder value creation.
  • "Today's announcements will strengthen our ability to drive better outcomes for patients with genetic diseases and deliver value to all stakeholders.
  • BioMarin plays a pivotal role in the treatment of genetic diseases thanks to its globally leading rare-disease portfolio.
  • We believe the changes announced today put BioMarin in the best position to realize its full potential, and we support Alexander Hardy as the right leader for this chapter of BioMarin's value creation story.

Walking Aid Market to Boom: $5.2 Billion Industry by 2034 as Disabilities and Aging Population Rise | Future Market Insights, Inc.

Retrieved on: 
Tuesday, December 12, 2023

NEWARK, Del., Dec. 12, 2023 /PRNewswire/ -- As per the latest analysis, the global walking aid market value is anticipated to total US$ 3.0 billion in 2024. Over the assessment period, walking aid sales are projected to expand with a CAGR of 5.7%, taking the overall valuation to US$ 5.2 billion by 2034.

Key Points: 
  • NEWARK, Del., Dec. 12, 2023 /PRNewswire/ -- As per the latest analysis, the global walking aid market value is anticipated to total US$ 3.0 billion in 2024.
  • Over the assessment period, walking aid sales are projected to expand with a CAGR of 5.7%, taking the overall valuation to US$ 5.2 billion by 2034.
  • Request Exclusive Sample Report: Walking Aid Market Strategic Insights: https://www.futuremarketinsights.com/reports/sample/rep-gb-18649
    Multiple factors are expected to stimulate the growth of the walking aid market during the assessment period.
  • These include the rising prevalence of disabilities, increasing cases of arthritis, a growing geriatric population, and favorable government initiatives.

Walking Aid Market to Boom: $5.2 Billion Industry by 2034 as Disabilities and Aging Population Rise | Future Market Insights, Inc.

Retrieved on: 
Tuesday, December 12, 2023

NEWARK, Del., Dec. 12, 2023 /PRNewswire/ -- As per the latest analysis, the global walking aid market value is anticipated to total US$ 3.0 billion in 2024. Over the assessment period, walking aid sales are projected to expand with a CAGR of 5.7%, taking the overall valuation to US$ 5.2 billion by 2034.

Key Points: 
  • NEWARK, Del., Dec. 12, 2023 /PRNewswire/ -- As per the latest analysis, the global walking aid market value is anticipated to total US$ 3.0 billion in 2024.
  • Over the assessment period, walking aid sales are projected to expand with a CAGR of 5.7%, taking the overall valuation to US$ 5.2 billion by 2034.
  • Request Exclusive Sample Report: Walking Aid Market Strategic Insights: https://www.futuremarketinsights.com/reports/sample/rep-gb-18649
    Multiple factors are expected to stimulate the growth of the walking aid market during the assessment period.
  • These include the rising prevalence of disabilities, increasing cases of arthritis, a growing geriatric population, and favorable government initiatives.

Global Electric Wheelchair Market Projected to Surge to $7.6 Billion by 2028

Retrieved on: 
Friday, November 17, 2023

Hospitals & clinics are projected to be the largest end-use industry segment, driven by the increasing need for patient mobility support.

Key Points: 
  • Hospitals & clinics are projected to be the largest end-use industry segment, driven by the increasing need for patient mobility support.
  • North America is expected to maintain its position as the largest regional market, bolstered by its robust healthcare infrastructure and government support.
  • Regional Analysis: Comprehensive breakdown of the electric wheelchair market in key regions.
  • This report addresses crucial questions such as:
    What are high-growth opportunities in the global electric wheelchair market by product type, end-use industry, and region?

Comprehensive Analysis: Global Bedsore Air Cushion Market Size, Trends, and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 24, 2023

A new comprehensive report on the global Bedsore Air Cushion market has been released, providing valuable insights into the industry's growth trends, market size, competitive landscape, and forecasts for the period of 2018 to 2028.

Key Points: 
  • A new comprehensive report on the global Bedsore Air Cushion market has been released, providing valuable insights into the industry's growth trends, market size, competitive landscape, and forecasts for the period of 2018 to 2028.
  • The report provides a comprehensive competitor analysis, featuring global key players in the Bedsore Air Cushion market, as well as emerging small players.
  • Additionally, the report categorizes the types of Bedsore Air Cushions, including Automatic Inflating Air Cushions with Electric Air Pump and Self-Inflating Air Cushions.
  • It provides a comprehensive view of the Bedsore Air Cushion market, offering valuable insights for stakeholders, industry players, and decision-makers.

Invacare Holdings Corporation Names Kai Zhu Senior Vice President and Chief Financial Officer

Retrieved on: 
Monday, June 26, 2023

Invacare Holdings Corporation (“Invacare” or “the company”), announced today that it has appointed Kai Zhu as Senior Vice President and Chief Financial Officer, effective July 1, 2023.

Key Points: 
  • Invacare Holdings Corporation (“Invacare” or “the company”), announced today that it has appointed Kai Zhu as Senior Vice President and Chief Financial Officer, effective July 1, 2023.
  • Mr. Zhu, 46, has served as Invacare’s Vice President Finance EMEA since April 2022 and has over two decades of financial leadership experience.
  • Kathleen P. Leneghan, Invacare’s current Senior Vice President and Chief Financial Officer, has announced her retirement from the company.
  • “On behalf of the Board of Directors, I am pleased to welcome Kai as our next Chief Financial Officer.

White Oak ABL and White Oak Commercial Finance Provide $40 Million Credit Facility to Invacare, a Leading Provider of Medical Equipment

Retrieved on: 
Tuesday, June 20, 2023

White Oak ABL, LLC and White Oak Commercial Finance, LLC, the asset-based lending affiliates of White Oak Global Advisors, LLC, (collectively, “White Oak”) provided a $40 million North America ABL credit facility (the “ABL Facility”) to Invacare Holdings Corporation (“Invacare” or the “Company”), a leading manufacturer and distributor of medical equipment used in non-acute care settings.

Key Points: 
  • White Oak ABL, LLC and White Oak Commercial Finance, LLC, the asset-based lending affiliates of White Oak Global Advisors, LLC, (collectively, “White Oak”) provided a $40 million North America ABL credit facility (the “ABL Facility”) to Invacare Holdings Corporation (“Invacare” or the “Company”), a leading manufacturer and distributor of medical equipment used in non-acute care settings.
  • “We at White Oak are excited to partner with Invacare and support their long-term growth plans and exit from bankruptcy.
  • With this strategic partnership, White Oak has once again demonstrated its ability to develop tailored ABL solutions to support the operations and sustained growth of middle market businesses,” said Tom Otte, Head of ABL.
  • “We are pleased to have secured the ABL Facility which provides additional flexibility for the North American business as we focus on executing our global transformation plan.

Generational Equity Advises Red Oak Medical Supply in Its Sale to Private Investor

Retrieved on: 
Thursday, June 15, 2023

Generational Equity , a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its client Emaan Medical Supply, Inc. (dba, Red Oak Medical Supply) to a Private Investor.

Key Points: 
  • Generational Equity , a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its client Emaan Medical Supply, Inc. (dba, Red Oak Medical Supply) to a Private Investor.
  • Founded in 1997, Red Oak Medical Supply (ROMS), located in Houston, Texas, is one of the leading medical supply retailers in Houston.
  • With more than 10,000 unique items in stock, ROMS is truly a one-stop-shop for all medical supplies in Houston.
  • "It was a pleasure working with the seller and buyer as both have similar values,” said Farahmandi.

Rehabilitation Equipment Market to Grow Significantly by 2029- Brandessence Market Research

Retrieved on: 
Monday, May 22, 2023

Some of the commonly used rehabilitation equipment are exercise machines, resistance weights and bands, assistive devices, motion devices, and coordination equipment, just to name a few.

Key Points: 
  • Some of the commonly used rehabilitation equipment are exercise machines, resistance weights and bands, assistive devices, motion devices, and coordination equipment, just to name a few.
  • The market research report on Global Rehabilitation Equipment Market by Brandessence Market Research sheds light on different parameters that are impacting the ongoing trends of this industry.
  • The Rehabilitation Equipment Market is anticipated to garner significant returns over the estimated timeline of 2022-2029.
  • Also, healthcare facilities often face budgetary issues in acquiring advanced rehabilitation equipment, impacting their ability to offer comprehensive rehabilitation programs.